User: Guest  Login
If you experience problems opening the document, please try this link.
Title:

Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies

Document type:
Zeitschriftenaufsatz
Author(s):
Ettl, Johannes; Im, Seock-Ah; Ro, Jungsil; Masuda, Norikazu; Colleoni, Marco; Schnell, Patrick; Bananis, Eustratios; Lu, Dongrui R.; Cristofanilli, Massimo; Rugo, Hope S.; Finn, Richard S.
Journal title:
Breast Cancer Research
Year:
2020
Journal volume:
22
Journal issue:
1
Fulltext / DOI:
doi:10.1186/s13058-020-01263-0
Publisher:
Springer Science and Business Media LLC
E-ISSN:
1465-542X
Date of publication:
12.03.2020
 BibTeX